peptide receptor radionuclide therapy (PRRT)

You have access
First-in-Humans Study of the SSTR Antagonist ¹⁷⁷Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy
Richard P. Baum, Jingjing Zhang, Christiane Schuchardt, Dirk Müller and Helmut Mäcke

Journal of Nuclear Medicine November 1, 2021, 62 (11) 1571-1581; DOI: https://doi.org/10.2967/jnumed.120.258889
You have access
¹⁸F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up Study
Tina Binderup, Ulrich Knigge, Camilla Bardram Johnbeck, Annika Loft, Anne Kiil Berthelsen, Peter Oturai, Jann Mortensen, Birgitte Federspiel, Seppo W. Langer and Andreas Kjaer

Journal of Nuclear Medicine June 1, 2021, 62 (6) 808-815; DOI: https://doi.org/10.2967/jnumed.120.244798
You have access
Peptide Receptor Radionuclide Therapy of Late-Stage Neuroendocrine Tumor Patients with Multiple Cycles of ¹⁷⁷Lu-DOTA-EB-TATE
Qingxing Liu, Jie Zang, Huimin Sui, Jiakun Ren, Hua Guo, Hao Wang, Rongxi Wang, Orit Jacobson, Jingjing Zhang, Yuejuan Cheng, Zhaohui Zhu and Xiaoyuan Chen

Journal of Nuclear Medicine March 1, 2021, 62 (3) 386-392; DOI: https://doi.org/10.2967/jnumed.120.248658
You have access
Combination of 5-Fluorouracil with Epigenetic Modifiers Induces Radiosensitization, Somatostatin Receptor 2 Expression, and Radioligand Binding in Neuroendocrine Tumor Cells In Vitro
Xi-Feng Jin, Christoph J. Auernhammer, Harun Ilhan, Simon Lindner, Svenja Nölting, Julian Maurer, Gerald Spöttl and Michael Orth

Journal of Nuclear Medicine September 1, 2019, 60 (9) 1240-1246; DOI: https://doi.org/10.2967/jnumed.118.224048
You have access
Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog ¹⁷⁷Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors
Jingjing Zhang, Hao Wang, Orit Jacobson, Yuejuan Cheng, Gang Niu, Fang Li, Chunmei Bai, Zhaohui Zhu and Xiaoyuan Chen

Journal of Nuclear Medicine November 1, 2018, 59 (11) 1699-1705; DOI: https://doi.org/10.2967/jnumed.118.209841

Main menu

User menu

Search

peptide receptor radionuclide therapy (PRRT)